Literature DB >> 7003852

The development and validation of an enzyme linked immunosorbent assay for malaria.

I A Quakyi.   

Abstract

ELISA has been evaluated and validated for malaria. It is sensitive, specific and reproducible. A comparison of ELISA and IFAT has been made, and there is a good correlation between the two tests. ELISA results can be assessed objectively. A small study on Caucasians with clinical malaria shows the value of ELISA as an immunodiagnostic tool. Its seroepidemiological value is also demonstrated, since it quickly reflects the changes in malaria transmission after a WHO malaria control programme in a malaria endemic area.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7003852

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN： 0303-4208


  5 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.

Authors:  Armead H Johnson; Rose G F Leke; Nancy R Mendell; Dewon Shon; Young Ju Suh; Dennis Bomba-Nkolo; Viviane Tchinda; Samuel Kouontchou; Lucy W Thuita; Anne Marie van der Wel; Alan Thomas; Anthony Stowers; Allan Saul; Ainong Zhou; Diane W Taylor; Isabella A Quakyi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar.

Authors:  B Dubois; P Deloron; P Astagneau; C Chougnet; J P Lepers
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

4.  Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection.

Authors:  P Deloron; B Dubois; J Y Le Hesran; D Riche; N Fievet; M Cornet; P Ringwald; M Cot
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

5.  Characterization of the humoral immune response in Plasmodium falciparum malaria. I. Estimation of antibodies to P. falciparum or human erythrocytes by means of microELISA.

Authors:  M Wahlgren; K Berzins; P Perlmann; A Björkman
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.